Product record
Glimepiride Pioglitazone Metformin: batches declared Not of Standard Quality
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts, Jan 2019, Jul 2026
2 batches of products named "Glimepiride Pioglitazone Metformin" (as printed by the testing lab) failed a CDSCO or state drug-testing laboratory test between January 2024 and October 2025. This is a record of specific batches, it does not mean the molecule or every brand is unsafe.
Records by type
2 records linked to Glimepiride Pioglitazone Metformin in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A failed batch is not a verdict on every pack of this product. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches
| Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| 424-73Mfg 2024-01 · Exp 2026-06 | Zee Laboratories 47Himachal Pradesh | The sample does not conform to claim as per Manufacturer Specification with respect to the test for "Assay" of Pioglitazone Hydrochloride equivalent to Pioglitazone.Assay | RDTL, GuwahatiCDSCO lab | Oct 2025 |
| MPT-22149Mfg 2022-09 · Exp 2024-08 | Magnatek EnterprisesHimachal Pradesh | Identification and Assay of Pioglitazone Hydrochloride calculated as PioglitazoneAssay | RDTL ChandigarhState lab | Jan 2024 |
How to use this. Match the batch number on your strip or bottle against the list. If your batch is listed, return it to the pharmacy and ask for a replacement; if not, the product is not on any alert as of July 2026. Check any batch number.